LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Turbocharged Thermal Cycling Leads to Ultrafast DNA Diagnostics

By LabMedica International staff writers
Posted on 12 Aug 2015
Image: Schematic representation of the photonic polymerase chain reaction (PCR) on a chip using light to rapidly heat and cool electrons at the surface of a thin film of gold (Photo courtesy of Luke Lee/BioPOETS laboratory).
Image: Schematic representation of the photonic polymerase chain reaction (PCR) on a chip using light to rapidly heat and cool electrons at the surface of a thin film of gold (Photo courtesy of Luke Lee/BioPOETS laboratory).
Nucleic acid amplification and quantification via polymerase chain reaction (PCR) is one of the most sensitive and powerful tools for clinical laboratories, precision medicine, personalized medicine, and other scientific fields.

Ultrafast multiplex PCR, characterized by low power consumption, compact size and simple operation, is ideal for timely diagnosis at the point-of-care (POC), but the use of a simple and robust PCR thermal cycler remains challenging for POC testing.

Bioengineers at the University of California (Berkeley, CA, USA) have developed a novel ultrafast photonic PCR method that combines the use of a thin gold (Au) film as a light-to-heat converter and light-emitting diodes (LEDs) as a heat source. The ultrafast photonic PCR method uses plasmonic photothermal light-to-heat conversion via photon-electron-phonon coupling.

The scientists used thin films of gold that were 120 nm thick. The gold was deposited onto a plastic chip with microfluidic wells to hold the PCR mixture with the DNA sample. The light source was an array of off-the-shelf LEDs positioned beneath the PCR wells. The peak wavelength of the blue LED light was 450 nm, tuned to get the most efficient light-to-heat conversion. They were able to cycle from 55 °C to 95 °C 30 times in less than five minutes. They tested the ability of the photonic PCR system to amplify a sample of DNA, and found that the results compared well with conventional PCR tests.

Luke P. Lee, PhD, a professor of bioengineering, and senior author of the study said, “This photonic PCR system is fast, sensitive and low-cost. It can be integrated into an ultrafast genomic diagnostic chip, which we are developing for practical use in the field. Because this technology yields point-of-care results, we can use this in a wide range of settings, from rural Africa to a hospital emergency room.” The study was published on July 31, 2015, in the journal Light: Science & Application.

Related Links:

University of California 


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Automatic CLIA Analyzer
Shine i9000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more